About Vapotherm
Vapotherm high-velocity therapy is mask-free non-invasive respiratory support and is a front-line tool for relieving respiratory distress—including hypercapnia, hypoxemia, and dyspnea. It allows for the fast, safe treatment of undifferentiated respiratory distress with one tool. The HVT 2.0 and Precision Flow systems’ mask-free interface delivers optimally conditioned breathing gases, making it comfortable for patients and reducing the risks and care complexities associated with mask therapies. While being treated, patients can talk, eat, drink and take oral medication.
- New Study Confirms Vapotherm’s Unicorn™ Cannula Provides Comparable Efficacy at Lower Flow RatesVapotherm, Inc., the global leader in mask-free noninvasive respiratory support, is proud to announce the publication of a new clinical study, Effect of Single-Prong Cannula Design with High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates, in Critical Care Explorations. The study demonstrates that the ProSoft® Unicorn™ Cannula, a single-prong high velocity therapy cannula, provides comparable relief of dyspnea at a significantly lower flow rates compared to traditional dual-prong cannulas.
- Vapotherm Introduces the Unicorn™ Cannula: A Next Generation, Single-Prong Cannula Designed for Optimal CO2 ClearanceVapotherm, Inc., a leader in mask-free noninvasive respiratory support, introduces the Unicorn Cannula, an innovative single-prong addition to the ProSoft® series. Designed to enhance CO₂ clearance and patient comfort, the Unicorn Cannula retains the proven small-bore technology while enhancing therapy effectiveness.
- HYPERACT Trial Published: A Paradigm Shift in Respiratory CareThe publication of “High-Velocity Nasal Insufflation vs Non-Invasive Positive Pressure Ventilation for Moderate Acute Exacerbation of COPD in the ED”
- Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADEDr. Jessica Whittle, Chief Medical Officer of Vapotherm, emphasized the company’s commitment to improving the lives of hypercapnic patients in the home. “Our mission is to improve quality of life and reduce hospital readmissions for patients who struggle with respiratory disease. Access365 will provide optimal treatment at home, especially for COPD patients, by combining the known benefits of nocturnal NIV with the comfort of high velocity therapy for daytime use.”
- Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT) Partnership enables Vapotherm to build a robust and secure solution 80% faster than the standard development timeline to meet data visualization and device management goals for HVT® 2.0 and future Home system
Meet our Senior Leadership Team
Joseph Army, President & Chief Executive Officer
Alvin Tan, VP R&D
Cara Main, VP R&D and Quality
David Blouin, VP North American Sales
David De Souza, VP Operations
Dan Van Hise, VP Marketing
Dorota McKay, Chief Accounting Officers and VP Controller
Jessica Whittle, Chief Medical Officer and VP of Clinical Research
Lindsay Becker, Vice President, Human Resources
Mike Webb, VP Regulatory
Saulo Areas, VP International Sales
Soundharya Nagasubramanian, VP Data Management, Connectivity and IT
Compliance Program & Declaration
Code of Business Conduct
Vapotherm, Inc is committed to ensuring that its business practices are conducted in an ethical and transparent manner and in compliance with all applicable laws, including the California Health and Safety Code §119400-119402 (the “California Code”).
Vapotherm, Inc has developed a Comprehensive Compliance Program, consistent with HHS-OIG guidance and in accordance with the AdvaMed Code of Ethics on Interactions with Health Care Professionals, a voluntary ethical code specifically tailored for the unique interactions between the medical technology industry and our health care professional partners. This program is reasonably designed to prevent and detect violations and meet the goals set forth by the State of California.
Compliance Declaration
As of May 23, 2025, to the best of its knowledge and based on a good faith understanding of the requirements of the California Code, Vapotherm, Inc declares that it is in compliance with its Comprehensive Compliance Program and the California Code.
For a copy of our compliance program please call +1(603)-658-0011.
Our
Story
We Do Work That Matters.
Open
Positions
Join the Vapotherm Team.
Contact Us
We’re Here To Help.
Learn More?
Request a demo and we’re happy to connect you with a team member!
CAUTION: US Federal law restricts this device to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at https://vapotherm.com/resources/support/precision-flow-reference/. For spontaneously breathing patients. High Velocity Therapy (HVT) does not provide total ventilatory requirements of the patient. It is not a ventilator. Decisions surrounding patient care depend on the physician’s professional judgment in consideration of all available information for the individual case, including escalation of care depending on patient condition.